When was Conexeu Sciences founded?

Conexeu Sciences was founded in 2023 and raised its 1st funding round 2 years after it was founded.

Where is Conexeu Sciences located?

Conexeu Sciences is headquartered in Reno, United States.

Who is the current CEO of Conexeu Sciences?

Ryan Hartwell of Conexeu Sciences. They have also founded 1 company.

How many employees does Conexeu Sciences have?

As of Sep 30, 2026, the latest employee count at Conexeu Sciences is 14.

Is Conexeu Sciences a funded company?

Conexeu Sciences is a funded company, having raised a total of $6.96M across 10 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 10, 2025.

When was the latest funding round of Conexeu Sciences?

Conexeu Sciences' latest funding was a $***** Post IPO round on Oct 15, 2026, with participation from 0 investor.

Where does Conexeu Sciences rank among its competitors?

Conexeu Sciences ranks 7th amongst 81 active competitors, of which 23 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Conexeu Sciences, which secured $1.5M in Oct, 2026.

Who are the top competitors of Conexeu Sciences?

Conexeu Sciences' top competitors include Acera Surgical, Organogenesis and GeniPhys. Among them, Conexeu Sciences secured the most recent funding round in October, 2026.

Conexeu Sciences - 2026 Company Profile, Team, Funding & Competitors

Conexeu Sciences is a public company based in Reno (United States), founded in 2023 by Ryan Hartwell and David Bogart. It operates as a Developer of products for skin restoration and wound care. Conexeu Sciences has raised $6.96M in funding. The company has 81 active competitors, including 23 funded and 4 that have exited. Its top competitors include companies like Acera Surgical, Organogenesis and GeniPhys.

Company Details

Developer of products for skin restoration and wound care. The company uses CXU Scaffold technology that enhances tissue regeneration for wound healing and superior epithelialization.

Website: conexeu.com
Email ID: *****@conexeu.com

Key Metrics

Founded Year

2023

Location

Reno, United States

Stage

Public

Total Funding

$6.96M in 10 rounds

Latest Funding Round

Post IPO, Oct 15, 2026, $*****

Ranked

7^th among 81 active competitors

Employee Count

14 as on Sep 30, 2026

Similar Companies

Acera Surgical & 89 more

Exit Details

Public

View Conexeu Sciences' full profile

Conexeu Sciences got listed on May 21, 2026.

Click here to take a look at Conexeu Sciences's IPO in detail

Conexeu Sciences has raised a total funding of $6.96M over 10 rounds. Its first funding round was on Apr 10, 2025.

Here is the list of recent funding rounds of Conexeu Sciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 15, 2026	1116246	Post IPO	1407325	2148551	2426517	8376913
Sep 01, 2026	6324985	Post IPO	9285782	4715125	1270353	5863022
Aug 24, 2026	9401041	Post IPO	8815742	3443243	6071077	2727532

Access funding benchmarks and valuations. Sign up today!

View details of Conexeu Sciences's funding rounds and investors

The founders of Conexeu Sciences are Ryan Hartwell and David Bogart. Ryan Hartwell is the CEO of Conexeu Sciences.

Here are the details of Conexeu Sciences' key team members:

Ryan Hartwell: Co-Founder & CEO of Conexeu Sciences.
David Bogart: Co-Founder of Conexeu Sciences.

View details of Conexeu Sciences's Founder profiles and Board Members

Conexeu Sciences' employee count trend

Conexeu Sciences has 14 employees as of Sep 26. Here is Conexeu Sciences's employee count trend over the years:

Employee count trend for Conexeu Sciences

Uncover Conexeu Sciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Conexeu Sciences include Acera Surgical, Organogenesis and GeniPhys. Here is the list of Top 10 competitors of Conexeu Sciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Acera Surgical 2013, St. Louis (United States), Acquired	Provider of synthetic electrospun scaffolds for regenerative medical applications	$6.32M	St. Louis Arch Angels, Missouri Technology ... & 1 others	59/100
2nd	Organogenesis 1985, Canton (United States), Public	Regenerative tissue innovations for advanced wound care and surgical solutions	$30M	Spring St. Group, Eastward Capital Partners ... & 2 others	55/100
3rd	GeniPhys 2014, Zionsville (United States), Series A	Developer of collagen polymers for tissue regeneration	$13.5M	Elevate Ventures, Plug and Play Tech Center ... & 3 others	53/100
4th	Encellin 2015, San Francisco (United States), Series A	Developer of regenerative materials	$18.1M	Khosla Ventures, SV Latam Capital & 8 others	50/100
5th	BioLab Holdings 2018, Mesa (United States), Unfunded	Manufacturer of synthetic antimicrobial matrices and single, dual, triple layer membranes	-	-	50/100
6th	BioTissue 2001, Miami (United States), Series C	Developer of regenerative biologic therapies for eye care	$110M	Ballast Point Ventures, RC Capital & 2 others	49/100
7th	Conexeu Sciences 2023, Reno (United States), Public	Developer of products for skin restoration and wound care	$6.96M	-	47/100
8th	Reapplix 2008, Rudersdal (Denmark), Series B	Developer of patch system for wound healing	$52.4M	Seed Capital, Novo Holdings & 9 others	46/100
9th	RenovoDerm 2016, Columbus (United States), Seed	Developer of nanofiber-based wound care devices	$775K	Proton Enterprises, Monte Carlo Capital & 1 others	46/100
10th	Polaroid Therapeutics 2022, Schlieren (Switzerland), Unfunded	Developer of antimicrobial solutions for wound healing	-	-	44/100